The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGILE THERAPEUTICS INC | COM | 00847L100 | 27,660 | 2,983,797 | SH | SOLE | 2,983,797 | 0 | 0 | ||
| CATALENT INC | COM | 148806102 | 34,475 | 1,106,729 | SH | SOLE | 1,106,729 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 112,985 | 3,293,060 | SH | SOLE | 3,293,060 | 0 | 0 | ||
| Chimerix Inc | COM | 16934W106 | 38,555 | 1,022,943 | SH | SOLE | 1,022,943 | 0 | 0 | ||
| Esperion Therapeutics Inc | COM | 29664W105 | 190,255 | 2,054,594 | SH | SOLE | 2,054,594 | 0 | 0 | ||
| INTERSECT ENT INC | COM | 46071F103 | 9,041 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| Lombard MED INC | COM | G55598109 | 3,572 | 886,363 | SH | SOLE | 886,363 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 42,984 | 3,452,493 | SH | SOLE | 3,452,493 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 0 | 0 | SH | SOLE | 0 | 0 | 0 | ||
| PERNIX THERAPEUTICS HLDGS IN | COM | 71426V108 | 21,487 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
| ROKA BIOSCIENCE INC | COM | 775431109 | 3,592 | 1,122,417 | SH | SOLE | 1,122,417 | 0 | 0 | ||
| SORRENTO THERAPEUTICS INC | COM NEW | 83587F202 | 20,386 | 1,763,500 | SH | SOLE | 1,763,500 | 0 | 0 | ||
| T2 BIOSYSTEMS INC | COM | 89853L104 | 39,162 | 2,523,300 | SH | SOLE | 2,523,300 | 0 | 0 | ||
| TransEnterix Inc | COM NEW | 89366M201 | 24,424 | 8,335,819 | SH | SOLE | 8,335,819 | 0 | 0 | ||
| VERSARTIS INC | COM | 92529L102 | 41,876 | 2,279,568 | SH | SOLE | 2,279,568 | 0 | 0 | ||
| ZELTIQ AESTHETICS INC | COM | 98933Q108 | 80,088 | 2,597,742 | SH | SOLE | 2,597,742 | 0 | 0 | ||
| Dermira Inc. | COM | 24983L104 | 16,916 | 1,102,046 | SH | SOLE | 1,102,046 | 0 | 0 | ||
| Paratek Pharmaceuticals, Inc. | COM | 699374302 | 21,341 | 682,680 | SH | SOLE | 682,680 | 0 | 0 | ||
| ADMA Biologics, Inc. | COM | 000899104 | 35,360 | 3,608,171 | SH | SOLE | 3,608,171 | 0 | 0 | ||